Tamoxifen Citrate

• Post Date:

  Jan 20,2017

• Expiry Date:

  Jul 19,2017

• Detailed Description:

  Cas No. :54965-24-1 Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, 4-hydroxytamoxifen.
  
  In other tissues such as the endometrium, Tamoxifen behaves as an agonist, and thus may be characterized as a selective estrogen-receptor modulator.
  Tamoxifen is the usual endocrine (anti-estrogen) therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting.

• CAS Registry Number:

  54965-24-1

• Synonyms:

  ;(z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxyl]-n,n-dimethyl-ethanamine-citrate;1-p-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene citrate;Tamoxiphen Citrate;2-{4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt);

• Molecular Formula:

  C₃₂H₃₄NO₈

• Molecular Weight:

  560.6159

• Molecular Structure:

  

• Hazard Symbols:

   T:Toxic;
  

• Risk Codes:

  R22:;
  R45:;
  

• Safety Description:

  S45:;
  S53:;
  

• Company:

  HongKong Blue Universal Co., Limited.     [ China ]        

• Contact:

  ElleFiled

• Tel:

  +8615658039754

• Fax:

• Email:

  ElleFiled@hotmail.com